- Research news
- Open Access
Genome Biology volume 3, Article number: spotlight-20021106-02 (2002)
Cell-cycle checkpoints ensure that damaged DNA is repaired prior to cell division. In an Advanced Online Publication in Nature Genetics, Puri et al. describe characterization of a differentiation checkpoint that operates in muscle cells in response to DNA-damaging agents (Nature Genetics, 4 November 2002; DOI:10.1038/ng1023). Treatment of the C2C12 myoblast cell line with different genotoxic drugs (cisplatin, etoposide, or methyl methane sulphate, MMS) blocked the progression of myogenic differentiation and induced cell-cycle arrest. Cisplatin and MMS prevented the transcriptional activity of the myogenic factor MyoD. This inhibition involves the c-Abl tyrosine kinase, but not the p53 or c-Jun proteins that have also been implicated in the DNA-damage response. Puri et al. show that MyoD is a direct target of the c-Abl kinase and that phosphorylation of MyoD is critical for inhibition by genotoxic drugs.
The DNA damage response: putting checkpoints in perspective.
Nature Genetics, [http://0-www.nature.com.brum.beds.ac.uk/ng]
About this article
Cite this article
Weitzman, J.B. Muscle checkpoint. Genome Biol 3, spotlight-20021106-02 (2002) doi:10.1186/gb-spotlight-20021106-02
- Myogenic Differentiation
- Nature Genetic
- C2C12 Myoblast
- Myoblast Cell Line
- Myogenic Factor